Canadian General Medical Center Complex Company

TADAWUL:9518.SR

6.44 (SAR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SAR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 25.61225.61255.12527.56245.21722.60942.31321.15638.91719.45840.45920.2330.18315.09234.38417.19229.83214.916
Cost of Revenue 19.85719.85737.79618.89831.00515.50329.96914.98526.28813.14427.65913.8617.7918.89521.40811.2917.6098.805
Gross Profit 5.7555.75517.3298.66414.2127.10612.3436.17212.6296.31412.86.3712.3936.19612.9755.90212.2236.111
Gross Profit Ratio 0.2250.2250.3140.3140.3140.3140.2920.2920.3250.3250.3160.3150.4110.4110.3770.3430.410.41
Reseach & Development Expenses 000000000000000000
General & Administrative Expenses 2.6872.6870.6760.6762.9532.9531.7251.7251.7581.7581.6241.6242.9442.9441.6161.6161.7521.752
Selling & Marketing Expenses 0.920.920.9230.9232.95303.1520.7561.75801.381-0.2342.94402.9180.151.7520
SG&A 3.8163.8163.2685.0355.9062.9534.1982.1813.5161.7583.0041.395.8882.9444.5341.7663.5031.752
Other Expenses 00-0000000000000000
Operating Expenses 3.8163.8163.2685.5255.9062.3524.1982.1263.5161.5773.0041.2245.8882.9034.5341.8453.5031.618
Operating Income 1.9391.93914.063.6298.3064.1538.1453.9919.1124.5569.7964.8416.5053.2538.4424.1368.724.36
Operating Income Ratio 0.0760.0760.2550.1320.1840.1840.1920.1890.2340.2340.2420.2390.2160.2160.2460.2410.2920.292
Total Other Income Expenses Net 0.4860.486-5.3710.7160.8660.4330.6390.4020.0750.0380.4090.261-0.181-0.091-0.384-0.108-0.066-0.033
Income Before Tax 2.4262.4268.6894.3459.1734.5868.7844.3929.1884.59410.2055.1026.3243.1628.0574.0298.6544.327
Income Before Tax Ratio 0.0950.0950.1580.1580.2030.2030.2080.2080.2360.2360.2520.2520.210.210.2340.2340.290.29
Income Tax Expense 0.7410.7410.980.491.1720.5861.0680.5341.250.6251.1040.5521.3610.6810.3030.1520.2550.128
Net Income 1.6851.6857.7093.8558.0014.0017.7163.8587.9383.9699.1014.554.9632.4817.7543.8778.3994.2
Net Income Ratio 0.0660.0660.140.140.1770.1770.1820.1820.2040.2040.2250.2250.1640.1640.2260.2260.2820.282
EPS 0.0220.0220.10.050.10.0520.10.050.10.0520.120.0590.0650.0320.10.5183.9942
EPS Diluted 0.0220.0220.10.050.10.0520.10.050.10.0520.120.0590.0650.0320.10.5183.9942
EBITDA 2.4362.43614.6013.6769.5014.56410.0284.49510.3735.01211.3125.4237.9273.78710.154.8149.8424.745
EBITDA Ratio 0.0950.0950.2650.1330.210.2020.2370.2120.2670.2580.280.2680.2630.2510.2950.280.330.318